Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Transplantation
|
June 18, 2010
Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation
Ben Carpenter, Tanzina Haque, Maria Dimopoulou, et al.
Haematologica
|
July 2, 2013
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party
Silvia Montoto, Paolo Corradini, Martin Dreyling, et al.
Blood
|
December 16, 2014
CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status
Rob S Sellar, Frederick Arce Vargas, Jake Y Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma
Kirsty J Thomson, Emma C Morris, Adrian Bloor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
Irit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity
Karl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma
Karl S Peggs, Irfan Kayani, Noha Edwards, et al.
British Journal of Haematology
|
December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality
Suparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
British Journal of Haematology
|
April 27, 2012
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009
John A Snowden, Rachel M Pearce, Julia Lee, et al.
British Journal of Haematology
|
March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning
William M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Transplantation
|
June 18, 2010
Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation
Ben Carpenter, Tanzina Haque, Maria Dimopoulou, et al.
Haematologica
|
July 2, 2013
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party
Silvia Montoto, Paolo Corradini, Martin Dreyling, et al.
Blood
|
December 16, 2014
CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status
Rob S Sellar, Frederick Arce Vargas, Jake Y Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma
Kirsty J Thomson, Emma C Morris, Adrian Bloor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
Irit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity
Karl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma
Karl S Peggs, Irfan Kayani, Noha Edwards, et al.
British Journal of Haematology
|
December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality
Suparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
British Journal of Haematology
|
April 27, 2012
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009
John A Snowden, Rachel M Pearce, Julia Lee, et al.
British Journal of Haematology
|
March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning
William M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Page
of 11